In females, no significant effect on body weight, composition or energy balance was observed following 6 mo of L2-Cmu treatment (Supplementary Fig
Medications with narrow therapeutic windows or those requiring consistent timing may need dose adjustment or alternative formulations
Participants consumed fewer calories per day without being instructed to dietconsistent with appetite and satiety signaling reported in published trials
Our interest in immunotherapy began with our dendritic cell research in the late 1990s
Importantly, Zepbound carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Tuy nhin, thuc cng c th gy ra mt s tc dng ph nh: bun nn, tiu chy, to bn hoc vim ty v khng ph hp cho ph n mang thai hoc ang cho con b